U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
PLAMOTAMAB
INN   USAN  
Official Name English
XENP13676
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB13676 .GAMMA.1-CHAIN), (265->230'),(268->233')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB13676 .GAMMA.1-CHAIN) DISULF
Systematic Name English
plamotamab [INN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA MONOMER ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD20 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20 ANTIGEN)), LINKED TO SCFV-H-CH2-CH3 ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN (T-CELL SURFACE ANTI
Systematic Name English
XMAB-13676
Code English
Plamotamab [WHO-DD]
Common Name English
XMAB13676
Code English
ANTI-CD20/CD3 MONOCLONAL ANTIBODY XMAB13676
Common Name English
PLAMOTAMAB [USAN]
Common Name English
IMMUNOGLOBULIN HALF-G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS MS4A1 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20) AND HOMO SAPIENS CD3 EPSILON (CD3E, LEU-4)), MONOCLONAL ANTIBODY, BISPECIFICGAMMA1 HEAVY CHAIN ANTI-MS4A1 (1-450) (VH (HOMO SAP
Systematic Name English
Code System Code Type Description
USAN
GH-170
Created by admin on Tue Apr 01 23:09:37 GMT 2025 , Edited by admin on Tue Apr 01 23:09:37 GMT 2025
PRIMARY
FDA UNII
5ENX424FNF
Created by admin on Tue Apr 01 23:09:37 GMT 2025 , Edited by admin on Tue Apr 01 23:09:37 GMT 2025
PRIMARY
NCI_THESAURUS
C130050
Created by admin on Tue Apr 01 23:09:37 GMT 2025 , Edited by admin on Tue Apr 01 23:09:37 GMT 2025
PRIMARY
CAS
2138442-31-4
Created by admin on Tue Apr 01 23:09:37 GMT 2025 , Edited by admin on Tue Apr 01 23:09:37 GMT 2025
PRIMARY
SMS_ID
100000182955
Created by admin on Tue Apr 01 23:09:37 GMT 2025 , Edited by admin on Tue Apr 01 23:09:37 GMT 2025
PRIMARY
INN
11020
Created by admin on Tue Apr 01 23:09:37 GMT 2025 , Edited by admin on Tue Apr 01 23:09:37 GMT 2025
PRIMARY
ACTIVE MOIETY
PLAMOTAMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966